Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
SRZN · against 1,327 other Healthcare companies
Ranked #1,295 of 1,328 · scores higher than 2% of peers
Bars: peers in each 10-point band of the overall score44 peers with an overall score of 10–19, including SRZN · Click a bar to see the companies
| Rank | Company | Market cap | Overall | Valuation | Growth | Profitability | Risk |
|---|---|---|---|---|---|---|---|
| 1 | 3.1B EUR (≈$3.4B) | 100 | 100 | 100 | 0 / 2 | ||
| 2 | 595M USD | 97 | 96 | 98 | 99 | 0 / 2 | |
| 2 | 261M USD | 97 | 93 | — | 98 | 0 / 2 | |
| 4 | 2.1B USD | 96 | 96 | 99 | 93 | 0 / 2 | |
| 4 | 15.6B DKK (≈$2.3B) | 96 | 96 | 99 | 96 | 0 / 2 | |
| 1,292 | 24M SEK (≈$2M) | 14 | 33 | 4 | 0 | 2 / 2 | |
| 1,292 | 158M USD | 14 | 33 | 10 | 7 | 2 / 2 | |
| 1,295 | 222M GBP (≈$288M) | 13 | 18 | 17 | 2 / 2 | ||
| 1,295 | 118M USD | 13 | 8 | 23 | 18 | 2 / 2 | |
| 1,295 | 354M USD | 13 | 8 | 9 | 6 | 2 / 2 | |
| 1,298 | 5.1B CNY (≈$709M) | 12 | 0 | 2 | 29 | 2 / 2 | |
| 1,298 | 35.2B JPY (≈$240M) | 12 | 8 | 7 | 3 | 2 / 2 | |
| 1,298 | 522M USD | 12 | 8 | 13 | 19 | 2 / 2 | |
| 1,301 | 17.6B CNY (≈$2.5B) | 11 | 0 | 5 | 32 | 2 / 2 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score